Imaging Guidelines and Recommendations for Diagnosis, Surveillance, and Management of Pediatric CNS and Spinal Tumors

Abstract

Central nervous system (CNS) tumors are the second most common cause of cancer in children when incidence rates of cancer are estimated according to the Indian population dynamics based on 2011 consensus. As per the estimates, CNS tumors account for 20.1% of cancer burden in children aged between 0 and 14 years and 16.8% when 0 to 19 years age group is considered. The most common pediatric brain tumors are astrocytoma and medulloblastoma followed by other embryonal tumors, craniopharyngioma, and ependymal tumors. The incidence of CNS tumors in children from India is similar to the western high-income countries, other than slightly higher incidence of craniopharyngioma in Indian children.

Keywords

MRI - pediatric brain tumors - protocol - spinal tumor

^† These authors share first authorship.

Publikationsverlauf

Artikel online veröffentlicht:
06. März 2023

• References

• 1 Arora RS, Bagai P, Bhakta N. Estimated national and state level incidence of childhood and adolescent cancer in India. Indian Pediatr 2021; 58 (05) 417-423
• 2 Jain A, Sharma MC, Suri V. et al. Spectrum of pediatric brain tumors in India: a multi-institutional study. Neurol India 2011; 59 (02) 208-211
• 3 Kaderali Z, Lamberti-Pasculli M, Rutka JT. The changing epidemiology of paediatric brain tumours: a review from the hospital for sick children. Childs Nerv Syst 2009; 25 (07) 787-793
• 4 Johnson KJ, Cullen J, Barnholtz-Sloan JS. et al. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev 2014; 23 (12) 2716-2736
• 5 Patel AP, Fisher JL, Nichols E. et al; GBD 2016 Brain and Other CNS Cancer Collaborators. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18 (04) 376-393
• 6 Satyanarayana L, Asthana S, Labani S P. Childhood cancer incidence in India: a review of population-based cancer registries. Indian Pediatr 2014; 51 (03) 218-220
• 7 Suresh SG, Srinivasan A, Scott JX, Rao SM, Chidambaram B, Chandrasekar S. Profile and outcome of pediatric brain tumors – experience from a tertiary care pediatric oncology unit in South India. J Pediatr Neurosci 2017; 12 (03) 237-244
• 8 Girardi F, Allemani C, Coleman MP. Worldwide trends in survival from common childhood brain tumors: a systematic review. J Glob Oncol 2019; 5: 1-25
• 9 Fangusaro J, Witt O, Hernáiz Driever P. et al. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 2020; 21 (06) e305-e316
• 10 Erker C, Tamrazi B, Poussaint TY. et al. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 2020; 21 (06) e317-e329
• 11 Cooney TM, Cohen KJ, Guimaraes CV. et al. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 2020; 21 (06) e330-e336
• 12 Warren KE, Vezina G, Poussaint TY. et al. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro-oncol 2018; 20 (01) 13-23
• 13 Avula S, Peet A, Morana G, Morgan P, Warmuth-Metz M, Jaspan T. European Society for Paediatric Oncology (SIOPE)-Brain Tumour Imaging Group. European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours. Childs Nerv Syst 2021; 37 (08) 2497-2508
• 14 Resende LL, Alves CAPF. Imaging of brain tumors in children: the basics-a narrative review. Transl Pediatr 2021; 10 (04) 1138-1168
• 15 Mata-Mbemba D, Zapotocky M, Laughlin S, Taylor MD, Ramaswamy V, Raybaud C. MRI characteristics of primary tumors and metastatic lesions in molecular subgroups of pediatric medulloblastoma: a single-center study. AJNR Am J Neuroradiol 2018; 39 (05) 949-955
• 16 Matsusue E, Fink JR, Rockhill JK, Ogawa T, Maravilla KR. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology 2010; 52 (04) 297-306
• 17 Pope WB, Young JR, Ellingson BM. Advances in MRI assessment of gliomas and response to anti-VEGF therapy. Curr Neurol Neurosci Rep 2011; 11 (03) 336-344
• 18 de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J. Management of pediatric low-grade glioma. Curr Opin Pediatr 2019; 31 (01) 21-27
• 19 Sturm D, Pfister SM, Jones DTW. Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. J Clin Oncol 2017; 35 (21) 2370-2377
• 20 Ater JL, Xia C, Mazewski CM. et al. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: a report from the Children's Oncology Group. Cancer 2016; 122 (12) 1928-1936
• 21 Ostrom QT, Gittleman H, Liao P. et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-oncol 2017; 19 (suppl _5): v1-v88
• 22 Louis DN, Perry A, Wesseling P. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
• 23 Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 2009; 10 (03) 258-266
• 24 Drapeau A, Walz PC, Eide JG. et al. Pediatric craniopharyngioma. Childs Nerv Syst 2019; 35 (11) 2133-2145
• 25 Fujimaki T. Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview. J Child Neurol 2009; 24 (11) 1439-1445
• 26 Zubair A, De Jesus O. Ommaya Reservoir. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Apr 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK559011/
• 27 Rampling R, James A, Papanastassiou V. The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy. J Neurol Neurosurg Psychiatry 2004; 75 (Suppl 2): ii24-ii30
• 28 Ater JL, Zhou T, Holmes E. et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol 2012; 30 (21) 2641-2647
• 29 Benesch M, Wagner S, Berthold F, Wolff JEA. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH). J Neurooncol 2005; 72 (02) 179-183
• 30 Chalil A, Ramaswamy V. Low grade gliomas in children. J Child Neurol 2016; 31 (04) 517-522
• 31 Segal D, Lidar Z, Corn A, Constantini S. Delay in diagnosis of primary intradural spinal cord tumors. Surg Neurol Int 2012; 3: 52
• 32 Koeller KK, Shih RY. Intradural extramedullary spinal neoplasms: radiologic-pathologic correlation. Radiographics 2019; 39 (02) 468-490
• 33 Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 2000; 20 (06) 1721-1749
• 34 Bansal S, Ailawadhi P, Suri A. et al. Ten years' experience in the management of spinal intramedullary tumors in a single institution. J Clin Neurosci 2013; 20 (02) 292-298
• 35 Schellinger KA, Propp JM, Villano JL, McCarthy BJ. Descriptive epidemiology of primary spinal cord tumors. J Neurooncol 2008; 87 (02) 173-179
• 36 Chamberlain MC, Tredway TL. Adult primary intradural spinal cord tumors: a review. Curr Neurol Neurosci Rep 2011; 11 (03) 320-328
• 37 Wen-qing H, Shi-ju Z, Qing-sheng T. et al. Statistical analysis of central nervous system tumors in China. J Neurosurg 1982; 56 (04) 555-564
• 38 Hirano K, Imagama S, Sato K. et al. Primary spinal cord tumors: review of 678 surgically treated patients in Japan. A multicenter study. Eur Spine J 2012; 21 (10) 2019-2026
• 39 Dikondwar AR, Dani AA. Spinal space occupying lesions - pathologic spectrum. J Med Sci Health 2016; 2 (01) 24-29
• 40 Banga MS, Sandeep BV, Kishan A, Dev AH, Devabhakthuni RB. Spinal cord tumors—our 5-year experience. Indian Journal of Neurosurgery 2022
• 41 Arora RK, Kumar R. Spinal tumors: trends from Northern India. Asian J Neurosurg 2015; 10 (04) 291-297
• 42 Engelhard HH, Villano JL, Porter KR. et al. Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina. J Neurosurg Spine 2010; 13 (01) 67-77
• 43 Narayan S, Rege SV, Gupta R. Clinicopathological study of intradural extramedullary spinal tumors and its correlation with functional outcome. Cureus 2021; 13 (06) e15733
• 44 Shih RY, Koeller KK. Intramedullary masses of the spinal cord: radiologic-pathologic correlation. Radiographics 2020; 40 (04) 1125-1145
• 45 Scibilia A, Terranova C, Rizzo V. et al. Intraoperative neurophysiological mapping and monitoring in spinal tumor surgery: sirens or indispensable tools?. Neurosurg Focus 2016; 41 (02) E18
• 46 Coronel EE, Lien RJ, Ortiz AO. Postoperative spine imaging in cancer patients. Neuroimaging Clin N Am 2014; 24 (02) 327-335